AbbVie, Inc. (ABBV)

205.07 -1.16 (-0.56%) USD  |  NYSE  |  Mar 20, 16:00
205.94 +0.87 (+0.42%) After-Hours: 20:00
More

AbbVie Research and Development Expense (Quarterly) : 2.579B for Dec. 31, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Amgen, Inc. 2.151B
Biogen, Inc. 434.00M
Gilead Sciences, Inc. 1.565B
Johnson & Johnson 4.268B
Eli Lilly & Co. 3.802B